Tolerability of Utidelone Capsule in Patients With Advanced Solid Tumors

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
The purpose of this trial is to evaluate the safety and tolerability of Utidelone Capsule in patients with advanced solid tumors and determine the maximum tolerated dose (MTD) and dose-limiting toxicity (DLT). The secondary objectives are to evaluate the pharmacokinetic profile of Utidelone Capsule in patients with advanced solid tumors, preliminarily assess the anti-tumor activity of Utidelone Capsule in patients with advanced solid tumors via objective radiologic tumor response using RECIST 1.1, and to recommend the dose and dosage regimen for subsequent clinical trials.
Epistemonikos ID: 2817bfee6d48952009e0753e5b943dfea87e043c
First added on: May 14, 2024